| Product Code: ETC7212290 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Angioedema Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 France Angioedema Market - Industry Life Cycle |
3.4 France Angioedema Market - Porter's Five Forces |
3.5 France Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 France Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 France Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 France Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 France Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 France Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 France Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients |
4.2.2 Technological advancements in diagnostic tools and treatment options |
4.2.3 Growing prevalence of angioedema in France due to environmental factors or genetic predisposition |
4.3 Market Restraints |
4.3.1 High cost of treatment for angioedema |
4.3.2 Limited availability of specialized healthcare facilities for angioedema management |
4.3.3 Stringent regulatory requirements for approval of new angioedema therapies |
5 France Angioedema Market Trends |
6 France Angioedema Market, By Types |
6.1 France Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 France Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 France Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 France Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 France Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 France Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 France Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 France Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 France Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 France Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 France Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 France Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 France Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 France Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 France Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 France Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 France Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 France Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 France Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 France Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 France Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 France Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 France Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 France Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 France Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 France Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 France Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 France Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 France Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 France Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 France Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 France Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 France Angioedema Market Import-Export Trade Statistics |
7.1 France Angioedema Market Export to Major Countries |
7.2 France Angioedema Market Imports from Major Countries |
8 France Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in angioedema diagnosis and management |
8.2 Percentage of patients with angioedema receiving timely and appropriate treatment |
8.3 Rate of adoption of new diagnostic tools and treatment options in the management of angioedema |
9 France Angioedema Market - Opportunity Assessment |
9.1 France Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 France Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 France Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 France Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 France Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 France Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 France Angioedema Market - Competitive Landscape |
10.1 France Angioedema Market Revenue Share, By Companies, 2024 |
10.2 France Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here